Insulet (NSDQ:PODD) and UnitedHealthcare (NYSE:UNH) inked a new network relationship last week, giving people enrolled in UnitedHealthcare’s commercial and Medicaid plans in-network coverage for Insulet’s Omnipod insulin delivery device.
“Through this new relationship, we are working together to help people access the insulin management technology they need to effectively manage their diabetes,” the companies wrote in a statement.
Get the full story at our sister site, Drug Delivery Business News.
The post Insulet nabs spot as in-network provider with UnitedHealthcare appeared first on MassDevice.